Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia
In the register
The register attaches this trial to Minoxidil (topical), currently at “Approved” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Not yet recruiting
- Declared phase
- Phase 3
- Sponsor
- Sheikh Zayed Federal Postgraduate Medical Institute
- Participants (registry)
- 200
- Start
- December 2025 (planned)
- Primary completion
- May 2026
- Study completion
- June 2026
- Last registry update
- December 2025
- Countries
- —
Conditions studied: Androgenic Alopecia
Interventions: Minoxidil 5 % Topical Spray, minoxidil, Placebo Spray, Placebo Tablet or Capsule
Other trials of Minoxidil (topical)
Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.
Efficacy & Safety of Minoxidil SL Tablets in Men With AGA
- NCT07056933Not yet recruiting
Effect of Minoxidil Solution Iontophoresis on Androgenic Alopecia
Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia
Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia
Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia
Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia
Treatment of Androgenetic Alopecia in Men for 24 Weeks
Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia
- NCT02486848Withdrawn
Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil
Comparison of Topical Minoxidil 5% in Ethanol Plus Propylene Glycol Versus Minoxidil 5% in Ethanol Alone in Treatment of Women With Female Pattern Hair Loss
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.